DXSE:XETRA:XETRA-Xtrackers - Stoxx Europe 600 Health Care Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 232.65

Change

0.00 (0.00)%

Market Cap

USD 0.14B

Volume

1.91K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-03 )

ETFs Containing DXSE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.02% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.02% 68% D+ 69% C-
Trailing 12 Months  
Capital Gain 18.28% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.28% 62% D 64% D
Trailing 5 Years  
Capital Gain 52.78% 76% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.78% 76% C+ 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 9.35% 66% D+ 65% D
Dividend Return 9.35% 65% D 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.74% 66% D+ 73% C
Risk Adjusted Return 107.01% 97% N/A 97% N/A
Market Capitalization 0.14B 39% F 35% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.